British Columbia Centre for Disease Control, Vancouver, Canada.
Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada.
LGBT Health. 2022 Aug-Sep;9(6):426-435. doi: 10.1089/lgbt.2021.0273. Epub 2022 May 10.
This study estimates the frequency of uninsurance for prescription drugs and cost-related medication nonadherence (CRNA) among lesbian, gay, and bisexual (LGB) persons in Canada, compared with the heterosexual population. Logistic regression was used to quantify associations between sexual orientation, insurance status, and CRNA within the national probability-based Canadian Community Health Survey, 2015-2016. This sample included 98,413 individuals aged 15-80 years, including 2803 LGB individuals. From our sample of Canadians, 22.2% of LGB respondents reported being uninsured for prescription drugs, compared with 20.0% of heterosexual persons (unadjusted odds ratio [UOR] 1.14, 95% confidence interval [CI] 0.97-1.35). LGB individuals had more than twice the odds of reporting CRNA compared with heterosexual individuals (UOR 2.48, 95% CI 1.99-3.10). This disparity was most pronounced among bisexual respondents, who had over three times the odds of reporting CRNA in comparison to heterosexual respondents (UOR 3.45, 95% CI 2.65-4.51). The odds ratio (OR) for CRNA comparing bisexual with heterosexual individuals remained statistically significant after adjustment for race/ethnicity, gender/sex, and age (OR 2.67, 95% CI 1.97-3.61) and was further attenuated with adjustment for partnership status, employment status, income, educational attainment, prescription drug insurance status, general health status, and immigration status (OR 2.09, 95% CI 1.51-2.89). LGB Canadians reported more CRNA but comparable prescription drug insurance frequencies to heterosexual persons. Factors pertaining to medication access (e.g., income, partnership status) and health needs appear to be the most important contributors to disparities.
本研究估计了加拿大同性恋、双性恋和异性恋(LGB)人群中未投保处方药和与费用相关的药物不依从(CRNA)的频率,与异性恋人群相比。 使用逻辑回归来量化性取向、保险状况和 CRNA 之间的关联,这是基于全国概率性加拿大社区健康调查,2015-2016 年。本样本包括 98413 名 15-80 岁的个体,其中包括 2803 名 LGB 个体。 在我们的加拿大样本中,22.2%的 LGB 受访者报告未投保处方药,而异性恋者为 20.0%(未调整优势比 [UOR] 1.14,95%置信区间 [CI] 0.97-1.35)。LGB 个体报告 CRNA 的可能性是异性恋个体的两倍多(UOR 2.48,95%CI 1.99-3.10)。这种差异在双性恋受访者中最为明显,他们报告 CRNA 的可能性是异性恋受访者的三倍多(UOR 3.45,95%CI 2.65-4.51)。在调整种族/民族、性别/性别和年龄后,比较双性恋和异性恋个体的 CRNA 的比值比(OR)仍然具有统计学意义(OR 2.67,95%CI 1.97-3.61),并且在调整伴侣关系状况、就业状况、收入、教育程度、处方药保险状况、总体健康状况和移民状况后进一步减弱(OR 2.09,95%CI 1.51-2.89)。LGB 加拿大报告的 CRNA 更多,但与异性恋者的处方药保险频率相当。与药物获取(例如,收入、伴侣关系状况)和健康需求相关的因素似乎是造成差异的最重要因素。